Ren Zhao

Dr. Ren Zhao


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2020 in BMC Molecular and Cell Biology
Verified
Journal Article
Open access
PDF file
YJYimei Jiang
Yimei Jiang
XJXiaopin Ji
Xiaopin Ji
KLKun Liu
Kun Liu
YSYiqing Shi
Yiqing Shi
CWChanggang Wang
Changgang Wang
RZRen Zhao
Ren Zhao
Background: Colorectal cancer (CRC) is a leading cancer and a major cause of death. Lipopolysaccharide (LPS), an abundant component in gut microbiome, is involved in CRC progression and metastasis, potentially through regulating the miRNA composition of CRC-derived exosomes. In this study, we aimed to identify miRNA species in exosome which regulates CRC progression after LPS stimulation. Results: Firstly, we discovered a shift of miRNA profile in CRC exosome after LPS stimulation. Among the differentially expressed miRNAs, we identified miR-200c-3p as a potential key regulator of CRC progression and metastasis. Retrospective analysis revealed that miR-200c-3p was elevated in CRC tumor tissues, but decreased in the serum exosome in CRC patients. In vitro experiments demonstrated that exosomal miR-200c-3p expression did not influence CRC cell proliferation, but negatively regulated their capacity of migration and invasion in the presence of LPS. miR-200c-3p level in exosome influenced exosomal expression of Zinc finger E-box-binding homeobox-1 (ZEB-1) mRNA, one of the miR-200c targets which affects migration and invasion capacity, and further altered ZEB-1 protein expression in CRC cell. In addition, exosomal miR-200c-3p promotes apoptosis of HCT-116 cells. Conclusions: Our findings indicate that exosomal miR-200c-3p inhibits CRC migration and invasion, and promotes their apoptosis after LPS stimulation. It is suggested as a potential diagnostic marker and therapeutic target of CRC.

10 December 2022 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
YJYimei Jiang
Yimei Jiang
QQQingqing Qiu
Qingqing Qiu
XJXiaoqian Jing
Xiaoqian Jing
ZSZijia Song
Zijia Song
YZYaqi Zhang
Yaqi Zhang
RZRen Zhao
Ren Zhao

14 June 2009 in The Chinese-German Journal of Clinical Oncology
Verified
Journal Article
Closed access
PDF file
LCLi Chen
Li Chen
HLHui Li
Hui Li
RZRen Zhao
Ren Zhao
JZJianwei Zhu
Jianwei Zhu